• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 142122-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Restenosis (4576)
Event Date 08/11/2023
Event Type  Injury  
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of restenosis leading to intervention and claudication/leg pain are listed in the biomimics 3d instructions for use and are known patient effects of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Event Description
The patient was enrolled in the mimics 3d usa post-market observational study.On (b)(6) 2022, the patient was implanted with one biomimics 3d (bm3d) 5.0 x 60 mm stent to treat a denovo lesion in the left superficial femoral artery (sfa) distal third.A retrograde approach was used and the lesion was stented and post-dilated with a percutaneous transluminal angioplasty (pta) balloon.On (b)(6) 2023, a restenosis of the treated segment (target lesion) was identified and it was reported as possibly related to the device and not related to the procedure.It was target lesion-related.It was identified at the patient's 12-month follow-up visit.The patient was experiencing rutherford class (rc) 3 symptoms in the left leg.Duplex ultrasound (dus) showed stenosis in the left distal sfa (target lesion).A diagnostic angio on (b)(6) 2023 showed severe in-stent restenosis at (b)(4).An intervention was performed on (b)(6) 2023.A laser atherectomy was performed within the existing stent, followed by drug coated/eluting balloon (dcb/deb).Residual stenosis was less than (b)(4) afterwards.The intervention was a target lesion/vessel revascularisation (tlr/tvr).The outcome was reported as resolved recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
block 5
parkmore east business park
galway, H91 V 0TX
EI  H91 V0TX
Manufacturer Contact
alan mcdonagh
block 5
parkmore east business park
galway, H91 V-0TX
EI   H91 V0TX
MDR Report Key19069142
MDR Text Key339671586
Report Number3011632150-2024-00017
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850381
UDI-Public(01)05391526850381(17)230929(11)220228(10)0000136621
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/09/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date09/29/2023
Device Catalogue Number142122-01
Device Lot Number0000136621
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/11/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/28/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN.
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient SexFemale
Patient Weight62 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-